نتایج جستجو برای: vardenafil

تعداد نتایج: 378  

2011
Youjun Di Min Zhao Yingchun Nie Fei Wang Jiagen Lv

A flow method of high-performance liquid chromatography (HPLC) seperation and chemiluminescence (CL) detection for sensitive vardenafil analysis in dietary supplements was developed. The vardenafil separation was achieved on a C18 column at 30°C using ethanol-H(3)PO(4) and ethylenediaminetetraacetic acid disodium salt (Na(2)EDTA) aqueous solution (25 : 75, v/v%) as mobile phase. The followed co...

Journal: :Hospital Pharmacy 2013

2014
Mohammed A. Taher

It was found that only vardenafil markedly reduced CaCl2-induced contractions in the phenylephrine-treated isolated pulmonary artery indicates that this additional mechanism could be related to blockade of Ca channels. The aim of the present study is to evaluate effects of vardinafil on fertility parameters. Thirty male rats were allocated into five groups, control (D.W.) (n=6) and test groups ...

2015
Ezgi İkiz Gediz Cahit Nacitarhan Edibe Minareci Gulay Sadan

In this study, we aimed to investigate the peripheral antinociception effects of specific phosphodiesterase 5 (PDE-5) inhibitor vardenafil on carrageenan-induced nociception in rats, and the role of calcium besides the L-arginine- nitric oxide (NO)- cyclic guanosine monophophate (cGMP) pathway in these effects. Hyperalgesia was induced by the intraplantar injection of 0.1 mL fresh carrageenan s...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008
Bernd Hohenstein Christoph Daniel Sandra Wittmann Christian Hugo

BACKGROUND Matrix expansion and mesangial proliferation are hallmarks of mesangial proliferative glomerulonephritis. Specific inhibition of PDE-5, an enzyme catalyzing the intracellular degradation of cyclic GMP, can be achieved by the inhibitor vardenafil. In this study, we investigated the effects of PDE-5 inhibition in the anti-Thy1 model in the rat in vivo. METHODS After disease induction...

Journal: :Emergency medicine journal : EMJ 2005
H H Veloso A A V de Paola

Vardenafil is a new oral phosphodiesterase inhibitor used for erectile dysfunction. We report a case admitted with a first-detected, symptomatic paroxysmal atrial fibrillation in a healthy patient after self-medication with vardenafil.

Journal: :Brain research 2009
Georg Royl Mustafa Balkaya Sabrina Lehmann Seija Lehnardt Katharina Stohlmann Ute Lindauer Matthias Endres Ulrich Dirnagl Andreas Meisel

Recent experimental studies in rodents suggest that treatment with inhibitors of phosphodiesterase type 5 (PDE5) (tadalafil, sildenafil, zaprinast) not only increases cerebral blood flow but also improves functional recovery after stroke. Here, we investigated in a mouse model of stroke the effects of vardenafil on survival, functional outcome and lesion size after experimental stroke. Mice wer...

Beyzagül Polat Mehmet Emrah Yaman, Onur Şenol, Şaziye Sezin Palabiyik Yücel Kadioğlu

Erectile dysfunction (ED) diseases have almost affected 100 million men all over the world. Orally administered phosphodiesterase 5 (PDE 5) inhibitors are the most used pharmaceutical formulations for the treatment of ED. In this study, it is aimed to investigate the metabolomics feature of orally administered vardenafil in rats. To carry out the experimental procedure eight male Wistar albino ...

2016
Salah A Sheweita Mona Wally Mostafa Hassan

Erectile dysfunction (ED) is a major health problem and is mainly associated with the persistent inability of men to maintain sufficient erection for satisfactory sexual performance. Millions of men are using sildenafil, vardenafil, and/or tadalafil for ED treatment. Cytochrome P450s (CYPs) play a central role in the metabolism of a wide range of xenobiotics as well as endogenous compounds. Sus...

2011
Roger Green Rodney W Hicks

BACKGROUND Erectile dysfunction (ED) is a well-documented medical condition that is expected to increase significantly over the next several decades, especially as men live longer and the prevalence of diabetes and cardiovascular diseases increase. Pharmacology agents are often the first line treatment approach. Newer solid dosage forms, known as orally disintegrating tablets (ODT), are now ava...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید